Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent RE43833 Thiazolidin-4-one derivatives

Patent RE43833 was granted and assigned to Actelion on November, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Actelion

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

RE43833

Patent Inventor Names

Christoph Binkert0

Michael Scherz0

Boris Mathys0

Oliver Nayler0

Claus Mueller0

Martin Bolli0

Date of Patent

November 27, 2012

Patent Application Number

13205768

Date Filed

August 9, 2011

Patent Citations Received

‌

US Patent 11771683 Dosing regimen for a selective S1P

‌

US Patent 11672783 Pharmaceutical combination comprising a selective S1P1 receptor agonist

Patent Primary Examiner

‌

Laura L. Stockton

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent RE43833 Thiazolidin-4-one derivatives

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API